Speck-Planche Alejandro, Cordeiro M N D S
REQUIMTE/Department of Chemistry and Biochemistry, University of Porto, 4169-007 Porto, Portugal.
Curr Top Med Chem. 2015;15(18):1801-13. doi: 10.2174/1568026615666150506144814.
Drug discovery is aimed at finding therapeutic agents for the treatment of many diverse diseases and infections. However, this is a very slow an expensive process, and for this reason, in silico approaches are needed to rationalize the search for new molecular entities with desired biological profiles. Models focused on quantitative structure-activity relationships (QSAR) have constituted useful complementary tools in medicinal chemistry, allowing the virtual predictions of dissimilar pharmacological activities of compounds. In the last 10 years, multi-target (mt) QSAR models have been reported, representing great advances with respect to those models generated from classical approaches. Thus, mt- QSAR models can simultaneously predict activities against different biological targets (proteins, microorganisms, cell lines, etc.) by using large and heterogeneous datasets of chemicals. The present review is devoted to discuss the most promising mt-QSAR models, particularly those developed for the prediction of protein inhibitors. We also report the first multi-tasking QSAR (mtk-QSAR) model for simultaneous prediction of inhibitors against biomacromolecules (specifically proteins) present in Gram-negative bacteria. This model allowed us to consider both different proteins and multiple experimental conditions under which the inhibitory activities of the chemicals were determined. The mtk-QSAR model exhibited accuracies higher than 98% in both training and prediction sets, also displaying a very good performance in the classification of active and inactive cases that depended on the specific elements of the experimental conditions. The physicochemical interpretations of the molecular descriptors were also analyzed, providing important insights regarding the molecular patterns associated with the appearance/enhancement of the inhibitory potency.
药物发现旨在寻找用于治疗多种不同疾病和感染的治疗剂。然而,这是一个非常缓慢且昂贵的过程,因此,需要采用计算机辅助方法来合理地寻找具有所需生物学特性的新分子实体。专注于定量构效关系(QSAR)的模型已成为药物化学中有用的补充工具,可对化合物不同的药理活性进行虚拟预测。在过去十年中,多靶点(mt)QSAR模型已有报道,相对于传统方法生成的模型而言代表了巨大的进步。因此,mt-QSAR模型可以通过使用大量且异质的化学数据集同时预测针对不同生物靶点(蛋白质、微生物、细胞系等)的活性。本综述致力于讨论最有前景的mt-QSAR模型,特别是那些为预测蛋白质抑制剂而开发的模型。我们还报告了首个用于同时预测针对革兰氏阴性菌中存在的生物大分子(特别是蛋白质)的抑制剂的多任务QSAR(mtk-QSAR)模型。该模型使我们能够考虑不同的蛋白质以及测定化学物质抑制活性的多种实验条件。mtk-QSAR模型在训练集和预测集中的准确率均高于98%,在根据实验条件的特定要素对活性和非活性情况进行分类时也表现出非常好的性能。还分析了分子描述符的物理化学解释,为与抑制效力的出现/增强相关的分子模式提供了重要见解。